Does OCRELIZUMAB Cause Maternal exposure timing unspecified? 103 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 103 reports of Maternal exposure timing unspecified have been filed in association with OCRELIZUMAB (OCREVUS). This represents 0.2% of all adverse event reports for OCRELIZUMAB.
103
Reports of Maternal exposure timing unspecified with OCRELIZUMAB
0.2%
of all OCRELIZUMAB reports
1
Deaths
10
Hospitalizations
How Dangerous Is Maternal exposure timing unspecified From OCRELIZUMAB?
Of the 103 reports, 1 (1.0%) resulted in death, 10 (9.7%) required hospitalization.
Is Maternal exposure timing unspecified Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCRELIZUMAB. However, 103 reports have been filed with the FAERS database.
What Other Side Effects Does OCRELIZUMAB Cause?
Covid-19 (11,454)
Fatigue (5,704)
Urinary tract infection (3,618)
Headache (3,036)
Multiple sclerosis (2,609)
Asthenia (2,509)
Nasopharyngitis (2,479)
Gait disturbance (2,384)
Pneumonia (2,333)
Pain (2,327)
What Other Drugs Cause Maternal exposure timing unspecified?
RITUXIMAB (402)
METHOTREXATE (350)
ADALIMUMAB (343)
DICLOFENAC (331)
TOCILIZUMAB (327)
HYDROXYCHLOROQUINE (309)
FOLIC ACID (304)
INFLIXIMAB (303)
LEFLUNOMIDE (302)
SECUKINUMAB (301)
Which OCRELIZUMAB Alternatives Have Lower Maternal exposure timing unspecified Risk?
OCRELIZUMAB vs OCRIPLASMIN
OCRELIZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OCRELIZUMAB vs OCTINOXATE\OCTOCRYLENE
OCRELIZUMAB vs OCTREOTIDE
OCRELIZUMAB vs OCTREOTIDE\OCTREOTIDE